Leavell Investment Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.49M Sell
17,935
-69
-0.4% -$23.6K 0.24% 108
2026
Q1
$6.33M Buy
18,004
+8
+0% +$2.85K 0.26% 99
2025
Q4
$5.89M Sell
17,996
-83
-0.5% -$26.3K 0.25% 100
2025
Q3
$5.1M Sell
18,079
-145
-0.8% -$42.1K 0.22% 110
2025
Q2
$5.09M Buy
18,224
+160
+0.9% +$45.3K 0.23% 105
2025
Q1
$5.63M Buy
18,064
+172
+1% +$50.8K 0.28% 89
2024
Q4
$4.66M Buy
17,892
+136
+0.8% +$40.4K 0.23% 102
2024
Q3
$5.72M Buy
17,756
+5,325
+43% +$1.74M 0.29% 84
2024
Q2
$3.88M Sell
12,431
-152
-1% -$44.7K 0.21% 108
2024
Q1
$3.58M Sell
12,583
-129
-1% -$37.7K 0.21% 111
2023
Q4
$3.66M Buy
12,712
+1,324
+12% +$361K 0.23% 106
2023
Q3
$3.06M Sell
11,388
-362
-3% -$90.3K 0.21% 117
2023
Q2
$2.61M Buy
11,750
+102
+0.9% +$23.7K 0.18% 134
2023
Q1
$2.82M Sell
11,648
-265
-2% -$65K 0.2% 129
2022
Q4
$3.13M Sell
11,913
-250
-2% -$67K 0.23% 113
2022
Q3
$2.74M Sell
12,163
-50
-0.4% -$12.1K 0.22% 122
2022
Q2
$2.97M Buy
12,213
+29
+0.2% +$7.11K 0.23% 115
2022
Q1
$2.95M Buy
12,184
+201
+2% +$46.2K 0.2% 125
2021
Q4
$2.7M Sell
11,983
-24
-0.2% -$5.07K 0.18% 129
2021
Q3
$2.55M Buy
12,007
+152
+1% +$35K 0.19% 127
2021
Q2
$2.95M Hold
11,855
0.24% 113
2021
Q1
$2.95M Buy
11,855
+223
+2% +$53.2K 0.24% 113
2020
Q4
$2.67M Sell
11,632
-175
-1% -$40.3K 0.23% 117
2020
Q3
$3M Hold
11,807
0.26% 99
2020
Q2
$2.79M Hold
11,807
0.27% 105
2020
Q1
$2.39M Hold
11,807
0.28% 105
2019
Q4
$2.85M Buy
11,807
+500
+4% +$110K 0.27% 107
2019
Q3
$2.19M Buy
11,307
+647
+6% +$124K 0.22% 116
2019
Q2
$1.96M Sell
10,660
-60
-0.6% -$10.7K 0.21% 123
2019
Q1
$2.04M Buy
10,720
+80
+0.8% +$15.3K 0.23% 117
2018
Q4
$2.07M Buy
10,640
+169
+2% +$33K 0.26% 109
2018
Q3
$2.17M Sell
10,471
-15
-0.1% -$2.96K 0.23% 116
2018
Q2
$1.94M Buy
10,486
+65
+0.6% +$11.5K 0.22% 119
2018
Q1
$1.78M Sell
10,421
-150
-1% -$27.5K 0.21% 128
2017
Q4
$1.84M Sell
10,571
-2,075
-16% -$367K 0.22% 128
2017
Q3
$2.36M Sell
12,646
-760
-6% -$135K 0.29% 105
2017
Q2
$2.31M Buy
13,406
+2,035
+18% +$331K 0.29% 103
2017
Q1
$1.87M Buy
11,371
+4,514
+66% +$750K 0.24% 111
2016
Q4
$1M Sell
6,857
-5,671
-45% -$853K 0.14% 154
2016
Q3
$2.09M Buy
12,528
+118
+1% +$20K 0.31% 98
2016
Q2
$1.89M Buy
12,410
+100
+0.8% +$15.5K 0.28% 106
2016
Q1
$1.85M Buy
12,310
+300
+2% +$44.6K 0.28% 104
2015
Q4
$1.95M Buy
12,010
+395
+3% +$62.1K 0.29% 96
2015
Q3
$1.61M Buy
11,615
+4,030
+53% +$635K 0.25% 111
2015
Q2
$1.16M Buy
7,585
+2,825
+59% +$453K 0.18% 150
2015
Q1
$761K Buy
4,760
+1,400
+42% +$220K 0.12% 193
2014
Q4
$535K Hold
3,360
0.08% 227
2014
Q3
$472K Hold
3,360
0.08% 240
2014
Q2
$398K Hold
3,360
0.06% 259
2014
Q1
$414K Sell
3,360
-205
-6% -$24.9K 0.07% 256
2013
Q4
$407K Buy
3,565
+200
+6% +$22.8K 0.07% 250
2013
Q3
$377K Hold
3,365
0.07% 251
2013
Q2
$332K Buy
+3,365
New +$349K 0.06% 262

Other funds holding AMGN

Leavell Investment Management's AMGN Position: Q2 2026 in Review

Leavell Investment Management reduced its Amgen (AMGN) stake by 0.38% in Q2 2026, selling an estimated $23.6K and leaving 17,935 shares worth $6.49M. The position accounts for 0.24% of the portfolio, ranked #108.

Leavell Investment Management first reported a position in AMGN in Q2 2013 and has held it in 53 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Leavell Investment Management held 17,935 shares of Amgen worth $6.49M as of Q2 2026.
  • Leavell Investment Management sold 69 Amgen shares in Q2 2026, an estimated $23.6K.
  • Amgen made up 0.24% of Leavell Investment Management's portfolio in Q2 2026, its #108 holding.
  • Leavell Investment Management first reported a position in Amgen in Q2 2013 and has held it in 53 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.